EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Synthesis of 2‐(Quinoxalin‐2‐yl)acetamides and Their Preliminary Cytotoxic and Antibacterial Activity

Cesar E Tovar-Roman, Eduardo Hernández-Vázquez iD, José A Rivera-Chávez

Chemistry & Biodiversity · 2026-01 · 23 (1)

DOI: 10.1002/cbdv.202503511 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 18.01.2026. Verfasst von Cesar E Tovar-Roman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Departamento De Química Orgánica, Instituto De Química, Universidad Nacional Autónoma de México (UNAM), Ciudad de México, México. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Antineoplastic Agents, Quinoxalines, Acetamides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: PAPIIT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Quinoxaline is an aza‐heterocycle found in some bioactive compounds. Thus, to enhance the pharmacological scope of this nucleus, we report a series of 19 acetamides decorated with a quinoxaline core. The synthesis involved the linkage of previously constructed bromoacetamides and hydroxyphenyl quinoxalines via an S N 2 reaction. The first series considered a 1,4‐substituted phenyl ring as a linker, and some derivatives showed moderate antibacterial activity against a panel of ESKAPE pathogens, especially against methicillin‐resistant Staphylococcus aureus (inhibition ranging from 10% to 60% at 100 µM). Interestingly, the activity dropped in the 1,3‐ and 1,2‐regioisomers. Furthermore, we tested the series against relevant human cancer cell lines, in which the ethyl derivative 10c inhibited the growth of breast, prostate, and colon tumors (43%, 48%, and 66%, respectively), whereas COS‐7 cells showed only 7.8% inhibition. Although these are preliminary in vitro findings, we corroborate the applicability of the quinoxaline heterocycle in the design of potential candidates against relevant pathologies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsAntineoplastic AgentsQuinoxalinesAcetamidesHumansMicrobial Sensitivity TestsAnimalsCell Line, TumorStructure-Activity RelationshipCell ProliferationDrug Screening Assays, AntitumorChlorocebus aethiopsMolecular StructureMethicillin-Resistant Staphylococcus aureus

Stichwörter der Autor:innen

antibacterialanti‐MRSAcytotoxicityquinoxaline

Substanzen

Anti-Bacterial AgentsAntineoplastic AgentsQuinoxalinesAcetamides

Autor:innen und Institutionen

  • Departamento De Química Orgánica, Instituto De Química, Universidad Nacional Autónoma de México (UNAM), Ciudad de México, México.
  • Departamento De Productos Naturales, Instituto De Química, Universidad Nacional Autónoma de México (UNAM), Ciudad de México, México.

ORCID-Profile: Eduardo Hernández-Vázquez

Förderung

  • PAPIIT

Zitieren

APA

Tovar-Roman, C. E., Hernández-Vázquez, E., & Rivera-Chávez, J. A. (2026). Synthesis of 2‐(Quinoxalin‐2‐yl)acetamides and Their Preliminary Cytotoxic and Antibacterial Activity. Chemistry & Biodiversity, 23(1). https://doi.org/10.1002/cbdv.202503511

Vancouver

Tovar-Roman CE, Hernández-Vázquez E, Rivera-Chávez JA. Synthesis of 2‐(Quinoxalin‐2‐yl)acetamides and Their Preliminary Cytotoxic and Antibacterial Activity. Chemistry & Biodiversity. 2026;23(1). doi:10.1002/cbdv.202503511

BibTeX
@article{TovarRoman2026,
  author = {Tovar-Roman, Cesar E and Hernández-Vázquez, Eduardo and Rivera-Chávez, José A},
  title = {Synthesis of 2‐(Quinoxalin‐2‐yl)acetamides and Their Preliminary Cytotoxic and Antibacterial Activity},
  journal = {Chemistry & Biodiversity},
  year = {2026},
  volume = {23},
  number = {1},
  doi = {10.1002/cbdv.202503511}
}
Kostenlos starten →